Nov 20, 2018
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles
Nov 15, 2018
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Nov 14, 2018
Averitas Pharma Commercializes Qutenza® in the US
Nov 14, 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Nov 08, 2018
Vivozon's Non-Opioid Pain Killer has been granted the FDA's Fast Track Designation through Regulatory Strategy Support from MMS
Nov 05, 2018
Grünenthal Acquires Global Rights for Qutenza®
Oct 31, 2018
Innovative Surgery Shown to Reduce Amputee Pain, Phantom Limb Sensations, According to New Study Published in the Annals of Surgery
Oct 04, 2018
HealthStartNJ LLC invests in study to advance the treatment of neuropathic pain
Sep 18, 2018
Global Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market Report 2018
Sep 17, 2018
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025
Sep 12, 2018
MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform
Sep 04, 2018
New Coverage Decision Extends Abbott's Innovative Pain Therapy Option to 22 Million Americans Living with Chronic Pain
Aug 14, 2018
Analgesics Market Poised to Register 5.0% CAGR Through 2028 - Future Market Insights
Aug 02, 2018
Kalypso Wellness Centers Partner with Renowned Pain Management Specialist, Dr. Ed Rubin, to Offer Kalypso Ketamine Infusion Treatments in New York
Jul 17, 2018
Global Pain Management Devices Market to Grow at a CAGR of 7.60% by 2023, Says TMR
Jun 25, 2018
GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain
Jun 11, 2018
Pharmaleads Presents New Data Showing DENKIs, a New Class of Painkillers, to be Devoid of Abuse Potential and Opiate Side-Effects
May 24, 2018
Cannabis Expo, CWCBExpo, Talks about the Possibilities of Medicinal Marijuana in Pain Management Patients
May 17, 2018
Theravance Biopharma to Host Key Opinion Leader Event Focused on the Unmet Medical Need in the Treatment of Neurogenic Orthostatic Hypotension
May 15, 2018
Kalypso Wellness Centers Groundbreaking Approach to Pain Treatment Leads to Company Reaching 3K Milestone